Investor/RT . . .
provides the online investor a software solution that turns a computer into a trading workstation.  Designed for active investors and traders, Investor/RT monitors, charts, and analyzes real-time market data. The program's analytical tools handle any Periodicity: Daily, Weekly, Monthly, Tick-by-Tick, Tick Bars, or Minute Bars of any duration.  Investor/RT provides a wide array of Chart Types:   Candlestick, Bar, Line, Point and Figure, Market Profile, Volume Profile, Raw Tick, Day Bar, Three Line Break, and Custom Profile . . . all dynamic and flexible, allowing you to paint your picture of the market and monitor it real time.  Investor/RT Also offers powerful Scanning and BackTesting, a built-in Chat capability, Email and Chat Alerts, Portfolio Management and Reporting, Custom Indicators, and much more...
All Markets, including Stocks, Mutual Funds, Futures, Options, Indices, Currencies, and Bonds, can be monitored trade-by-trade. Whether you actively track only a few securities or wish to follow thousands of securities in search of new trading opportunities, Investor/RT is the tool for you.
Real-time and Delayed Data is delivered through your Internet Connection, Cable TV Transmission, Satellite Dish, or FM Receiver Box supplied by your Data Service.  The end-of-day data feeds download information via the Internet.
You may download, install, and evaluate the functionality of the software at no charge.  If you have a subscription to one of our compatible data services and would like to activate Investor/RT with your data feed, a live thirty day trial is available for $49.  To order the Investor/RT Trial Package click here now, and then return to this page to download Investor/RT.  The One Month Trial can be used with the Data Service of your choice: DTN, Signal, eSignal, BMI, QFeed, InterQuote, or myTrack. The Trial Package includes a Printed Manual and the Investor/RT CD-ROM containing software and additional reference material. The $49 trial fee may be applied toward the purchase of Investor/RT after the trial period.